Anti-REV Capsid Protein Polyclonal Antibody from ProteoGenix; catalogue ARO-A22243; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-REV Capsid Protein Polyclonal Antibody: Unlocking the Potential of Biotech Research
The Anti-REV Capsid Protein Polyclonal Antibody is a powerful tool for biotech researchers looking to unlock the potential of their studies. This highly specific antibody targets the REV capsid protein, a key player in viral replication and infection. With its unique ability to inhibit REV capsid function, this antibody offers a wide range of applications and experimental uses.
REV capsid protein is a crucial component of retroviruses, including HIV, that allows for viral assembly and release. By targeting this protein, the Anti-REV Capsid Protein Polyclonal Antibody effectively blocks the production of new viruses, hindering their ability to spread and cause harm. This makes it an essential tool for studying the mechanisms of viral replication and developing potential treatments.
The Anti-REV Capsid Protein Polyclonal Antibody has a wide range of applications in biotech research. It can be used to study the role of REV capsid protein in viral infection and replication, as well as its potential as a therapeutic target. This antibody is also valuable in drug discovery and development, as it can help identify compounds that inhibit REV capsid function and potentially block viral replication.
The versatility of the Anti-REV Capsid Protein Polyclonal Antibody allows for a variety of experimental use cases. It can be used in Western blotting, ELISA, and immunofluorescence assays to detect REV capsid protein expression and localization. Additionally, this antibody can be used in in vitro and in vivo studies to investigate the effects of REV capsid inhibition on viral replication and infection.
This antibody is specifically designed for researchers studying retroviruses, HIV, viral replication, and drug discovery. By targeting the REV capsid protein, it offers a unique approach to understanding and potentially treating these viruses. With its high specificity and versatility, the Anti-REV Capsid Protein Polyclonal Antibody is a valuable addition to any biotech research arsenal.
ProteoGenix catalogue number ARO-A22243. For research use only.
Target: Gag protein; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Gag protein |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
